The rapid sterility testing market is expected to experience significant growth between 2023 and 2032, driven by increasing demand for sterility tests and the expanding biotechnology industry. According to a report by Market Research Future, the market is projected to grow from $2.3 billion in 2023 to $4.3 billion by 2032, with a compound annual growth rate of 8.20 percent during this period.
Factors contributing to the expansion of the rapid sterility testing market include growing concerns about the safety of biological medicinal products and technological advancements that have led to more efficient sterility testing. Techniques such as membrane filtration sterility testing, particularly for liquid formulations, are driving growth in the industry.
The European region holds the second-largest share of the rapid sterility testing market, with countries like Germany and the UK leading in market share and growth. Companies like Charles River Laboratories, Merck KGaA, and Thermo Fisher Scientific are investing heavily in research and development to expand their product lines and contribute to the overall growth of the market.
